US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 8.120
  • +0.280+3.57%
Close Apr 26 16:00 ET
  • 8.310
  • +0.190+2.34%
Pre 07:11 ET
1.93BMarket Cap-5139P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 27, 2024

Revenue(YoY)

10.89M

-20.36%
EPS(YoY)

-0.42

-35.48%
Analyst Rating

Buy

Mar 31, 2024

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 13.583M--
--2024/Q1-- / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
--2023/Q310.533M / 12.870M--
--2023/Q211.017M / 11.915M--
--2023/Q112.134M / 13.154M--
--2022/Q413.676M / 24.000M--
--2022/Q313.160M / 6.850M--
--2022/Q27.674M / 5.400M--
--2022/Q15.333M / 83.950M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 13.583M--
--2024/Q1-- / 13.067M--
Feb 27, 20242023/Q410.891M / 20.352M--
--2023/Q310.533M / 12.870M--
--2023/Q211.017M / 11.915M--
--2023/Q112.134M / 13.154M--
--2022/Q413.676M / 24.000M--
--2022/Q313.160M / 6.850M--
--2022/Q27.674M / 5.400M--
--2022/Q15.333M / 83.950M--

Unlock Free Earnings Estimates

Recursion Pharmaceuticals Earnings Reports

  • Recursion Pharmaceuticals | 10-K: Annual report

    Feb 29 08:33 ET

  • Recursion Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 08:08 ET

  • Recursion Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 08:08 ET

  • Recursion Pharmaceuticals | 10-Q: Q1 2023 Earnings Report

    May 8, 2023 08:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 31, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg